Sophisticated Receptors For Next-Generation Cell Therapies.
Our modular receptors unlock a new era of safer, cost-effective, and potent treatments for cancer and autoimmune disease.
Introducing MARC: Modular Actuation Receptor Cells
Safe, Persistent, Potent
Despite enormous potential, CAR-T therapy remains limited by its high toxicity and poor therapeutic persistence, especially in the context of solid tumors.
MARC technology is the solution.
Investors & Partners
